ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Alector, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.95+0.11 (+5.98%)
Close on Oct 19, 2026
- Market cap
- $216.89M
- P/E (TTM)
- –
- Dividend yield
- –
Alector statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Alector | Industry median |
|---|---|---|
| Market Cap | $217.73M | $164.85M |
| Enterprise Value | $54.78M | $87.06M |
| PS Ratio | 15.71 | 3.60 |
Enterprise value
| Measure | Alector | Industry median |
|---|---|---|
| EV / Sales | 3.95 | 2.43 |
Income (trailing twelve months)
| Measure | Alector | Industry median |
|---|---|---|
| Revenue | $13.86M | $57.94M |
| Operating Income | -$126.49M | -$21.44M |
| Pretax Income | -$117.56M | -$14.45M |
| Net Income | -$117.85M | -$22.46M |
| EBITDA | -$121.95M | -$16.91M |
| EPS (Diluted) | -$1.10 | -$0.83 |
Margins
| Measure | Alector | Industry median |
|---|---|---|
| Operating Margin | -912.4% | -44.5% |
| Pretax Margin | -848.0% | -13.0% |
| Profit Margin | -850.1% | -39.2% |
| EBITDA Margin | -879.7% | -31.3% |
| FCF Margin | -1142.5% | -8.85% |
Returns
| Measure | Alector | Industry median |
|---|---|---|
| Return on Equity (ROE) | -385.1% | -53.1% |
| Return on Assets (ROA) | -42.1% | -41.0% |
| Return on Capital Employed (ROCE) | -75.0% | -37.8% |
Growth
| Measure | Alector | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -82.9% | 6.01% |
| Revenue Growth (3Y CAGR) | -46.0% | 2.25% |
| Revenue Growth (5Y CAGR) | -0.05% | 6.42% |
Balance sheet
| Measure | Alector | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $172.80M | $62.42M |
| Total Debt | $9.85M | $120.13M |
| Net Cash (Debt) | $162.95M | $15.68M |
| Net Cash Per Share | $1.46 | $0.66 |
| Equity (Book Value) | -$9.97M | $48.79M |
| Book Value Per Share | -$0.09 | $1.36 |
| Tangible Book Value | -$9.97M | $23.06M |
| Working Capital | $145.85M | $75.77M |
Financial position
| Measure | Alector | Industry median |
|---|---|---|
| Current Ratio | 5.26 | 3.30 |
| Quick Ratio | 5.05 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Alector | Industry median |
|---|---|---|
| Operating Cash Flow | -$158.23M | -$12.35M |
| Capital Expenditures | -$160.00K | -$1.06M |
| Free Cash Flow | -$158.39M | -$20.28M |
| FCF Per Share | -$1.42 | -$0.42 |
Efficiency
| Measure | Alector | Industry median |
|---|---|---|
| Asset Turnover | 0.05 | 0.38 |
| Revenue Per Employee | $134.59K | $398.96K |
| Profits Per Employee | -$1.14M | -$703.34K |
| Employee Count | 103 | 74 |
Dividends and yields
| Measure | Alector | Industry median |
|---|---|---|
| Earnings Yield | -54.1% | -22.7% |
| FCF Yield | -72.7% | -9.07% |
Shares
| Measure | Alector | Industry median |
|---|---|---|
| Shares Outstanding | 111,657,000 | 58,179,650 |
| Shares Change (YoY) | 9.70% | 11.1% |
| Shares Change (QoQ) | 0.57% | 0.54% |
| Float | 101,038,000 | 49,173,100 |
| Shares Held by Insiders | 9.51% | 11.6% |
| Shares Held by Institutions | 85.8% | 59.4% |
Taxes
| Measure | Alector | Industry median |
|---|---|---|
| Income Tax | $298.00K | $91.50K |
Scores
| Measure | Alector | Industry median |
|---|---|---|
| Altman Z-Score | -7.54 | -0.24 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Alector's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.